Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/20399879

Download in:

View as

General Info

PMID
20399879